Company / Operating Income per Share
4D Molecular Therapeutics, Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.10
FY2025
5-year range
-$4.10 / -$2.12
FY2021-FY2025
Trend
-56.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 6 years, ranging from $-9.80 in FY2020 to $-2.12 in FY2021.
Based on SEC 10-K filings.
-4.10 in FY2025.
Declined from $-3.37 to $-4.10 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 56.5% year-over-year.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.10 | -56.5% |
| FY2024 | -$2.62 | +22.3% |
| FY2023 | -$3.37 | -52.4% |
| FY2022 | -$2.21 | -4.2% |
| FY2021 | -$2.12 | +78.3% |
| FY2020 | -$9.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026